The treatment comparison reveals GHK-Cu discontinuation profile proving more favorable than retinoids (less dependency, no rebound, better benefit retention) while similar to vitamin C and niacinamide (gradual decline, moderate long-term retention, low dependency)
It does not describe syringe barrel capacity or needle thickness
While no prediction is a guarantee of success, this information can help in the choice of which drugs to test first in patients, as well as which are the least likely to succeed
[110,118,119] Furthermore, nanotechnology-based strategies enable the delivery of immunomodulatory agents such as immunosuppressants to target specific immune cells and tissues
Continue through the decision path Questions answered on this page What does the evidence for bpc-157 tb-500 blend actually show
Often, B is given as a separate injection if needed